These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37530986)

  • 1. Utilization of opportunistic cervical cancer screening in Nigeria.
    Habila MA; Sagay E; Obeng-Kusi M; Ali MJ; Magaji FA; Shambe IH; Daru PH; Jacobs ET; Madhivanan P; Sagay AS; Musa J
    Cancer Causes Control; 2024 Jan; 35(1):9-20. PubMed ID: 37530986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria.
    Magaji FA; Mashor MI; Anzaku SA; Hinjari AR; Cosmas NT; Kwaghe BV; Ali JM; Christian EN; Sagay AS; Chandler A; Khan I; Murphy RL; Hou L; Musa J
    BMC Public Health; 2024 Jan; 24(1):193. PubMed ID: 38229083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the COVID-19 pandemic on routine HIV care and cervical cancer screening in North-Central Nigeria.
    Habila MA; Obeng-Kusi M; Ali MJ; Magaji FA; Shambe IH; Daru PH; Jacobs ET; Madhivanan P; Sagay AS; Musa J
    BMC Womens Health; 2023 Nov; 23(1):640. PubMed ID: 38037005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer and pap smear awareness and utilization of pap smear test among Federal civil servants in North Central Nigeria.
    Hyacinth HI; Adekeye OA; Ibeh JN; Osoba T
    PLoS One; 2012; 7(10):e46583. PubMed ID: 23049708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of social marketing on the knowledge, attitude, and uptake of pap smear among women residing in an urban slum in Lagos, Nigeria.
    Olubodun T; Balogun MR; Odeyemi KA; Osibogun A; Odukoya OO; Banjo AA; Sonusi SE; Olubodun AB; Ogundele OOP; Dolapo DC
    BMC Womens Health; 2022 Feb; 22(1):42. PubMed ID: 35164717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiences and unmet needs of women undergoing Pap smear cervical cancer screening: impact on uptake of cervical cancer screening in south eastern Nigeria.
    Chigbu CO; Onyebuchi AK; Egbuji CC; Ezugwu EC
    J Cancer Educ; 2015 Mar; 30(1):81-5. PubMed ID: 24980966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study.
    Dal Maso L; Franceschi S; Lise M; De' Bianchi PS; Polesel J; Ghinelli F; Falcini F; Finarelli AC;
    BMC Cancer; 2010 Jun; 10():310. PubMed ID: 20565935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between patient-reported HIV status and provider recommendation for screening in an opportunistic cervical Cancer screening setting in Jos, Nigeria.
    Musa J; Achenbach CJ; Evans CT; Jordan N; Daru PH; Hou L; Murphy RL; Adewole IF; Simon MA
    BMC Health Serv Res; 2018 Nov; 18(1):885. PubMed ID: 30466437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The need to incorporate routine cervical cancer counselling and screening in the management of HIV positive women in Nigeria.
    Rabiu KA; Akinbami AA; Adewunmi AA; Akinola OI; Wright KO
    Asian Pac J Cancer Prev; 2011; 12(5):1211-4. PubMed ID: 21875269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with the intention to undergo Pap smear testing in the rural areas of Indonesia: a health belief model.
    Sumarmi S; Hsu YY; Cheng YM; Lee SH
    Reprod Health; 2021 Jun; 18(1):138. PubMed ID: 34193195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unmet cancer screening need of HIV-positive women in southeastern Nigeria.
    Dim CC; Dim NR; Ezegwui HU; Ikeme AC
    Medscape J Med; 2009; 11(1):19. PubMed ID: 19295940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge, attitude and practice of cervical cancer screening among women attending gynecology clinics in a tertiary level medical care center in southeastern Nigeria.
    Mbamara SU; Ikpeze OC; Okonkwo JE; Onyiaorah IV; Ukah CO
    J Reprod Med; 2011; 56(11-12):491-6. PubMed ID: 22195332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inequalities in reported use of cervical screening in Estonia: results from cross-sectional studies in 2004-2020.
    Suurna M; Orumaa M; Ringmets I; Pärna K
    BMC Womens Health; 2022 Dec; 22(1):545. PubMed ID: 36566176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sociodemographic and gynaecological factors that influence uptake of cervical cancer screening. A cross-sectional study in Calabar, Nigeria.
    Ago BU; Efiok EE; Abeng SE
    Afr Health Sci; 2022 Dec; 22(4):96-103. PubMed ID: 37092061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
    Açikgöz A; Ergör G
    Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rural Zulu women's knowledge of and attitudes towards Pap smears and adherence to cervical screening.
    Godfrey MAL; Mathenjwa S; Mayat N
    Afr J Prim Health Care Fam Med; 2019 Oct; 11(1):e1-e6. PubMed ID: 31588773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
    Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical Epithelial Abnormalities and Associated Factors among HIV-Infected Women in Lagos, Nigeria: A Cytology-Based Study.
    Okunade KS; Badmos KB; Soibi-Harry AP; Garba SR; Ohazurike EO; Ozonu O; Akanmu AS; Ogunsola FT; Abdulkareem FB; Anorlu RI
    Acta Cytol; 2023; 67(3):248-256. PubMed ID: 36516788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceived Barriers to Cervical Cancer Screening Uptake among Women of an Urban Community in South-Eastern Nigeria.
    Ubah C; Nwaneri AC; Anarado AN; Iheanacho PN; Odikpo LC
    Asian Pac J Cancer Prev; 2022 Jun; 23(6):1959-1965. PubMed ID: 35763637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing the prevalence of cervical cancer screening in Malaysia: a nationwide survey.
    Chan YM; Ismail MZH; Khaw WF
    BMC Womens Health; 2023 Jul; 23(1):389. PubMed ID: 37491253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.